BRPI0606475A2 - 2-oxo-3-ciano-1,6a-diaza-tetrahidro-fluorantenos 1,5,6-substituìdos - Google Patents

2-oxo-3-ciano-1,6a-diaza-tetrahidro-fluorantenos 1,5,6-substituìdos

Info

Publication number
BRPI0606475A2
BRPI0606475A2 BRPI0606475-2A BRPI0606475A BRPI0606475A2 BR PI0606475 A2 BRPI0606475 A2 BR PI0606475A2 BR PI0606475 A BRPI0606475 A BR PI0606475A BR PI0606475 A2 BRPI0606475 A2 BR PI0606475A2
Authority
BR
Brazil
Prior art keywords
alkyl
substituted
diaza
oxo
cyano
Prior art date
Application number
BRPI0606475-2A
Other languages
English (en)
Inventor
Bart Rudolf Romanie Kesteleyn
Pierre Jean-Marie Bernard Raboisson
De Vreken Wim Van
Maxime Francis Jean-Marie Canard
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0606475A2 publication Critical patent/BRPI0606475A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

2-OXO-3-CIANO-1 ,6a-DIAZA-TETRAHIDROFLUORANTENOS 1,5,6-SUBSTITUìDOS. A presente invenção refere-se a compostos inibitórios de HIV da fórmula: sais e estereoisómeros dos mesmos, em que R^ 1^ e R^ 2^ são hidrogênio ou C~ 1-10~ alquila opcionalmente substituida; R^ 3^ é: (a) n é 1, 2 ou 3; R^ 3a^ é nitro, dano, amina, halo, hidróxi, C~ 1-4~ alquilóxi, hidroxicarbonila, aminocarbonua, C~ 1-4~ alquiloxicarbonila, mono ou di (C~ 1-4~ alquil)aminocarbonila, C~ 1-4~ alquilcarbonila, metanimidamidila, mono ou di(C~ 1-4~ alquil)metanimidamidila, N-hidróxi-metanimidamidila ou Het; ou 3R é um sistema de anel heterocíclico aromático monociclico ou bicíclico, em que um, dois, três ou quatro elementos no anel são nitrogênio, oxigênio e enxofre e em que os elementos restantes no anel são átomos de carbono; e em que cada um dos referidos sistemas de anel heterocíclicos podem ser opcionalmente substituidos; X é -NR^ 7^- -O- ou -S-; composições farmacêuticas contendo esses compostos, métodos para preparo desses compostos e composições.
BRPI0606475-2A 2005-01-10 2006-01-10 2-oxo-3-ciano-1,6a-diaza-tetrahidro-fluorantenos 1,5,6-substituìdos BRPI0606475A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05100092 2005-01-10
US68470605P 2005-05-26 2005-05-26
PCT/EP2006/050106 WO2006072636A2 (en) 2005-01-10 2006-01-10 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes as anti-infective agents

Publications (1)

Publication Number Publication Date
BRPI0606475A2 true BRPI0606475A2 (pt) 2009-06-30

Family

ID=34938497

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606475-2A BRPI0606475A2 (pt) 2005-01-10 2006-01-10 2-oxo-3-ciano-1,6a-diaza-tetrahidro-fluorantenos 1,5,6-substituìdos

Country Status (12)

Country Link
US (1) US7514427B2 (pt)
EP (1) EP1838709B1 (pt)
JP (1) JP2008526814A (pt)
CN (1) CN101103029B (pt)
AR (1) AR056918A1 (pt)
AT (1) ATE538121T1 (pt)
AU (1) AU2006204475B2 (pt)
BR (1) BRPI0606475A2 (pt)
CA (1) CA2584425A1 (pt)
RU (1) RU2389730C2 (pt)
TW (1) TW200637862A (pt)
WO (1) WO2006072636A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072534A1 (es) 2008-07-25 2010-09-01 Gilead Sciences Inc Compuestos antivirales
JP5890522B2 (ja) 2011-08-05 2016-03-22 ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド 呼吸器合胞体ウイルス感染症処置用化合物
WO2015174511A1 (ja) * 2014-05-16 2015-11-19 塩野義製薬株式会社 Ｈｉｖ複製阻害作用を有する３環性複素環誘導体
WO2016194806A1 (ja) * 2015-05-29 2016-12-08 塩野義製薬株式会社 Ｈｉｖ複製阻害作用を有する含窒素３環性誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1927A (en) * 2002-11-15 2008-12-10 Tibotec Pharm Ltd Substituted indolepyridinium as anti-infective compounds

Also Published As

Publication number Publication date
WO2006072636A3 (en) 2006-12-14
RU2389730C2 (ru) 2010-05-20
EP1838709B1 (en) 2011-12-21
AU2006204475A1 (en) 2006-07-13
EP1838709A2 (en) 2007-10-03
RU2007130550A (ru) 2009-02-20
JP2008526814A (ja) 2008-07-24
CA2584425A1 (en) 2006-07-13
AU2006204475B2 (en) 2011-03-10
US20080167296A1 (en) 2008-07-10
CN101103029B (zh) 2010-12-29
AR056918A1 (es) 2007-11-07
US7514427B2 (en) 2009-04-07
CN101103029A (zh) 2008-01-09
ATE538121T1 (de) 2012-01-15
WO2006072636A2 (en) 2006-07-13
TW200637862A (en) 2006-11-01

Similar Documents

Publication Publication Date Title
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
BRPI0507065B8 (pt) derivados de quinolina, composição que os compreende, seu processo de preparação e seu uso como inibidores micobacterianos
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
BR0010391A (pt) Composto, composição farmacêutica, método de preparação de um composto, e, uso de um composto
BR112013000868A2 (pt) derivados de pirazol [1,5a] e tieno [3,2b] pirimidina como modulares de irak4
BR112014027181A2 (pt) derivados de benzamida para a inibição da atividade de abl1, abl2 e bcr-abl1
NO20090628L (no) Pyridizinon derivativater
BRPI0709633B8 (pt) derivados de piridina e pirimidina como antagonistas de mglur2, composição farmacêutica e uso dos mesmos
NO20085212L (no) Nye pyridinanaloger
UY30070A1 (es) Derivados diamina como inhibidores de leucotrieno a4 hidrolasa
BRPI0814065B8 (pt) derivados de alcoóis de 1-fenil-2-piridinil alquila como inibidores da fosfodiesterase
GEP20156330B (en) Aryl-and heteroarylcarbonyl derivatives of hexahydro- indenopyridine and octahydrobenzoquinoline
WO2009043320A3 (en) Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
UA109525C2 (xx) Алкіламідна сполука і її застосування
EP2012780A4 (en) SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES AS POTENTE PARP HEMMER
NO20085087L (no) Nye heterocykliske forbindelser
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
BRPI0517955A (pt) indolizinas substituìdas e derivados como agentes de snc
BR112014005581A2 (pt) compostos inibidores de enzima
BR112021020964A2 (pt) Inibidor seletivo de quinase jak1
MX341342B (es) Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
BRPI0417268A (pt) benzimidazóis que contêm morfolinila, como inibidores da replicação de vìrus sinciciais respiratórios

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.